ECSP034692A - Antagonistas de receptores de histamina - Google Patents

Antagonistas de receptores de histamina

Info

Publication number
ECSP034692A
ECSP034692A EC2003004692A ECSP034692A ECSP034692A EC SP034692 A ECSP034692 A EC SP034692A EC 2003004692 A EC2003004692 A EC 2003004692A EC SP034692 A ECSP034692 A EC SP034692A EC SP034692 A ECSP034692 A EC SP034692A
Authority
EC
Ecuador
Prior art keywords
histamine
receptor
receiver antagonists
histamine receiver
antagonists
Prior art date
Application number
EC2003004692A
Other languages
English (en)
Inventor
Stephen Jenkinson
Mark Anthony O'reilly
Michael Andrew Trevethick
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of ECSP034692A publication Critical patent/ECSP034692A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Otolaryngology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención proporciona una combinación de (a) un antagonista de receptor H1 de histamina y (b) un antagonista que es al menos 10 veces más selectivo para el receptor H4 de histamina en comparación con el receptor H3 de histamina que es al menos 10 veces más selectivo para el receptor H4 de histamina en comparación con el receptor 3 de histamina; y sus composiciones y usos.
EC2003004692A 2001-01-17 2003-07-17 Antagonistas de receptores de histamina ECSP034692A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0101223.6A GB0101223D0 (en) 2001-01-17 2001-01-17 Histamine receptor antagonists

Publications (1)

Publication Number Publication Date
ECSP034692A true ECSP034692A (es) 2003-08-29

Family

ID=9906993

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2003004692A ECSP034692A (es) 2001-01-17 2003-07-17 Antagonistas de receptores de histamina

Country Status (32)

Country Link
EP (1) EP1353657A1 (es)
JP (1) JP2004517883A (es)
KR (1) KR20030069216A (es)
CN (1) CN1486178A (es)
AP (1) AP2002002401A0 (es)
AR (1) AR032101A1 (es)
BG (1) BG107834A (es)
BR (1) BR0206502A (es)
CA (1) CA2435121A1 (es)
CR (1) CR6983A (es)
CZ (1) CZ20031853A3 (es)
DO (1) DOP2002000325A (es)
EA (1) EA200300537A1 (es)
EC (1) ECSP034692A (es)
EE (1) EE200300335A (es)
GB (1) GB0101223D0 (es)
GT (1) GT200200003A (es)
HU (1) HUP0302767A2 (es)
IL (1) IL156087A0 (es)
IS (1) IS6818A (es)
MA (1) MA26980A1 (es)
MX (1) MXPA03006408A (es)
NO (1) NO20033223L (es)
OA (1) OA12440A (es)
PA (1) PA8537101A1 (es)
PL (1) PL362793A1 (es)
PY (1) PY0200477A (es)
SK (1) SK8572003A3 (es)
SV (1) SV2003000849A (es)
TN (1) TNSN02003A1 (es)
WO (1) WO2002056871A2 (es)
ZA (1) ZA200304180B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030133931A1 (en) * 2001-12-21 2003-07-17 Robin Thurmond Use of histamine H4 receptor antagonist for the treatment of inflammatory responses
CA2497788A1 (en) * 2002-09-06 2004-03-18 Janssen Pharmaceutica, N.V. Use of histamine h4 receptor modulators for the treatment of allergy and asthma
US20050090527A1 (en) * 2003-01-28 2005-04-28 Schering Corporation Combination of H1, H3 and H4 receptor antagonists for treatment of allergic and non-allergic pulmonary inflammation, congestion and allergic rhinitis
US8236786B2 (en) * 2008-08-07 2012-08-07 Pulmagen Therapeutics (Inflammation) Limited Respiratory disease treatment
WO2013151982A1 (en) 2012-04-03 2013-10-10 Arena Pharmaceuticals, Inc. Methods and compounds useful in treating pruritus, and methods for identifying such compounds
PL2858647T3 (pl) 2012-06-08 2018-10-31 Sensorion Inhibitory receptora h4 do leczenia szumów usznych
CN119823227B (zh) * 2025-01-14 2025-07-04 广州迪卡德营养科技有限公司 一种益生菌的制备方法及其在治疗过敏性鼻炎中的用途

Also Published As

Publication number Publication date
HUP0302767A2 (hu) 2003-11-28
DOP2002000325A (es) 2003-01-31
IS6818A (is) 2003-05-15
EE200300335A (et) 2003-12-15
CA2435121A1 (en) 2002-07-25
PL362793A1 (pl) 2004-11-02
IL156087A0 (en) 2003-12-23
BG107834A (bg) 2004-01-30
TNSN02003A1 (fr) 2005-12-23
WO2002056871A2 (en) 2002-07-25
NO20033223D0 (no) 2003-07-16
JP2004517883A (ja) 2004-06-17
GB0101223D0 (en) 2001-02-28
PY0200477A (es) 2004-06-01
PA8537101A1 (es) 2002-08-29
SK8572003A3 (en) 2004-07-07
BR0206502A (pt) 2003-10-21
AP2002002401A0 (en) 2002-03-31
CN1486178A (zh) 2004-03-31
MXPA03006408A (es) 2003-10-15
EA200300537A1 (ru) 2004-02-26
OA12440A (en) 2006-05-22
NO20033223L (no) 2003-07-16
SV2003000849A (es) 2003-01-13
AR032101A1 (es) 2003-10-22
ZA200304180B (en) 2004-06-15
EP1353657A1 (en) 2003-10-22
KR20030069216A (ko) 2003-08-25
CZ20031853A3 (cs) 2004-07-14
CR6983A (es) 2003-11-25
GT200200003A (es) 2002-08-19
MA26980A1 (fr) 2004-12-20

Similar Documents

Publication Publication Date Title
AU3652102A (en) Compounds and their uses
PA8567001A1 (es) Composicion de ziprasidona y controles sinteticos
PA8527201A1 (es) Peptidos ciclados con actividad agonista para el receptor de la melanocortina-4 (mc4-r)
DE60222396D1 (de) N-(2-arylethyl) benzylamine als 5-ht6 rezeptor-antagoniste
BR0015963A (pt) Compostos de uréia antagonistas receptor muscarìnico, composições farmacêuticas compreendendo tais compostos e método de preparação destes compostos
NO993350L (no) Vitronectin-reseptor-antagonister
MX9302618A (es) Antagonistas de endotelina de fenil sulfonamidas.
PT1305286E (pt) Ciclopentanoindoles composicoes que contem os referidos compostos e metodos de tratamento
MXPA03002845A (es) Asociacion de un antagonista del receptor cb1 y de sibutramina, las composiciones farmaceuticas que los contienen y su utilizacion para el tratamiento de la obesidad.
HN2002000299A (es) Derivados del 3- azabiciclo[3.1.0] hexano
UY27800A1 (es) Utilizacion de inhibidores de la transduccion de senales inducida por egfr para el tratamiento de la hiperplasia de la prostata benigna (hps) /hipertrofia de la prostata.
DOP2002000325A (es) Antagonistas de receptores de histamina
DE60132798D1 (de) Zusammensetzung einer natriumkanal-blockierenden verbindung
DK1313485T3 (da) Anvendelse af en aldosteronreceptorantagonist til forbedring af kognitiv funktion
ECSP034558A (es) Moduladores del receptor estrogeno
DK0978284T3 (da) Anvendelse af 15-keto-prostaglandin-E-forbindelser som endothelinantagonister
UY26627A1 (es) Antagonistas de receptores de il-8
UY27124A1 (es) Antagonistas de receptores de histamina
ES2155187T3 (es) Antagonistas biciclicos de taquicinas, preparacion de estos antagonistas y su utilizacion en compuestos farmaceuticos.
DK1420789T3 (da) Anvendelse af aktivstoffer med my-opioid-receptoragonistisk virkning og opioid-receptorantagonistisk virkning som kombinationslægemidler til cancerbehandling
ATE387201T1 (de) Pharmazeutische kombination von tenatoprazole und einem histamin-h2-rezeptor antagonisten
MXPA04001878A (es) Composiciones medicinales que comprenden antagonista del receptor de angiotensina ii.
UY26893A1 (es) Combinación farmacéutica de antagonistas de la angiotensina ii e inhibidores de la enzima de conversión de la angiotensina i
DE60220699D1 (de) Tibolonformulierungen
EP1117681A4 (en) Peptides